Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel A Iñiguez

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Cancer Research|August 4, 2004
Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanismRaquel Grau, Miguel A Iñiguez, Manuel Fresno
The Journal of Biological Chemistry|January 6, 2005
Expression and function of the nuclear factor of activated T cells in colon carcinoma cells: involvement in the regulation of cyclooxygenase-2Javier Duque, Manuel Fresno, Miguel A Iñiguez
The Journal of Biological Chemistry|May 22, 2002
Protein kinase Czeta phosphorylates nuclear factor of activated T cells and regulates its transactivating activityBelén San-Antonio, Miguel A Iñiguez, Manuel Fresno
The Biochemical Journal|December 14, 2005
Peroxisome-proliferator-activated receptor alpha agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1Raquel Grau, Carmen Punzón, Manuel Fresno, et al.
Cardiovascular Research|February 7, 2006
Prostanoid signal transduction and gene expression in the endothelium: role in cardiovascular diseasesArántzazu Alfranca, Miguel A Iñiguez, Manuel Fresno, et al.
Cellular Signalling|April 3, 2007
Cot/Tpl2 and PKCzeta cooperate in the regulation of the transcriptional activity of NFATc2 through the phosphorylation of its amino-terminal domainElena Gómez-Casero, Belen San-Antonio, Miguel A Iñiguez, et al.
Cellular Signalling|December 6, 2005
Up-regulation of cyclooxygenase-2 by interleukin-1beta in colon carcinoma cellsJavier Duque, Manuel D Díaz-Muñoz, Manuel Fresno, et al.
Cellular Signalling|September 24, 2004
Effect of phosphodiesterase 4 inhibitors on NFAT-dependent cyclooxygenase-2 expression in human T lymphocytesJosé L Jimenez, Miguel A Iñiguez, M Angeles Muñoz-Fernández, et al.
Trends in Molecular Medicine|March 5, 2003
Cyclooxygenase-2: a therapeutic target in angiogenesisMiguel A Iñiguez, Antonio Rodríguez, Olga V Volpert, et al.
The Biochemical Journal|January 25, 2012
Involvement of PGE2 and the cAMP signalling pathway in the up-regulation of COX-2 and mPGES-1 expression in LPS-activated macrophagesManuel D Díaz-Muñoz, Inés C Osma-García, Manuel Fresno, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Cancer Research|August 4, 2004
Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanismRaquel Grau, Miguel A Iñiguez, Manuel Fresno
The Journal of Biological Chemistry|January 6, 2005
Expression and function of the nuclear factor of activated T cells in colon carcinoma cells: involvement in the regulation of cyclooxygenase-2Javier Duque, Manuel Fresno, Miguel A Iñiguez
The Journal of Biological Chemistry|May 22, 2002
Protein kinase Czeta phosphorylates nuclear factor of activated T cells and regulates its transactivating activityBelén San-Antonio, Miguel A Iñiguez, Manuel Fresno
The Biochemical Journal|December 14, 2005
Peroxisome-proliferator-activated receptor alpha agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1Raquel Grau, Carmen Punzón, Manuel Fresno, et al.
Cardiovascular Research|February 7, 2006
Prostanoid signal transduction and gene expression in the endothelium: role in cardiovascular diseasesArántzazu Alfranca, Miguel A Iñiguez, Manuel Fresno, et al.
Cellular Signalling|April 3, 2007
Cot/Tpl2 and PKCzeta cooperate in the regulation of the transcriptional activity of NFATc2 through the phosphorylation of its amino-terminal domainElena Gómez-Casero, Belen San-Antonio, Miguel A Iñiguez, et al.
Cellular Signalling|December 6, 2005
Up-regulation of cyclooxygenase-2 by interleukin-1beta in colon carcinoma cellsJavier Duque, Manuel D Díaz-Muñoz, Manuel Fresno, et al.
Cellular Signalling|September 24, 2004
Effect of phosphodiesterase 4 inhibitors on NFAT-dependent cyclooxygenase-2 expression in human T lymphocytesJosé L Jimenez, Miguel A Iñiguez, M Angeles Muñoz-Fernández, et al.
Trends in Molecular Medicine|March 5, 2003
Cyclooxygenase-2: a therapeutic target in angiogenesisMiguel A Iñiguez, Antonio Rodríguez, Olga V Volpert, et al.
The Biochemical Journal|January 25, 2012
Involvement of PGE2 and the cAMP signalling pathway in the up-regulation of COX-2 and mPGES-1 expression in LPS-activated macrophagesManuel D Díaz-Muñoz, Inés C Osma-García, Manuel Fresno, et al.
Pageof 2